Sickle cell anemia day hospital: An approach for the management of uncomplicated painful crises

Blood

Volumn 95, Issue 4, 2000, Pages 1130-1137

  Benjamin, Lennette J ^a,b   Swinson, Gwendolyn I ^a   Nagel, Ronald L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DAY HOSPITAL; ECONOMIC ASPECT; EMERGENCY WARD; FEMALE; HOSPITAL MANAGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SICKLE CELL ANEMIA;

EID: 0034651592     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.4.1130.003k03a_1130_1136     Document Type: Article

References (61)

1. Reid CD, Charache S, Lubin B, Johnson CS, Ohene-Frempong K. Management and Therapy of Sickle Cell Disease. Rockville, MD: US Dept of Health and Human Services; 1995. NIH Publication 95-2117.
2. Platt OS, Brambilla J, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330: 1639-1644.
3. Shapiro BS. Management of painful episodes in sickle cell disease. In: Schlechter NL, Berde CB, Yaster M, eds. Pain in Infants, Children and Adolescents. Baltimore, MD: Williams and Wilkins; 1993:385.
4. Benjamin LJ. Conventional and experimental approaches to the management of acute vaso-occlusive pain. In: Mankad VN, Moore RB, eds. Sickle Cell Disease, Pathophysiology, Diagnosis, and Management. Westport, CT: Praeger Publisher; 1992:248.
5. Embury SH, Hebbel RP, Mohandas N, Steinberg, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press Ltd.; 1994.
6. Kaul DK, Fabry ME, Nagel RL. The pathophysiology of vascular obstruction in the sickle syndromes. Blood Reviews. 1996;10:29-44.
7. Francis RB, Jr., Johnson CS. Vascular occlusion in sickle cell disease: Current concepts and unanswered questions. Blood. 1991;77:1405-1414.
8. Ballas SK. The sickle cell painful crisis in adults: phases and objective signs. Hemoglobin. 1995; 19:323-333.
9. Nadel C, Portadin G. Sickle cell crisis: Psychological factors associated with onset. NYS J Med. 1977;77:1075-1078.
10. Gil KM. Coping with sickle cell disease pain. Ann of Behavioral Med. 1989;11:49.
11. Whitten CF, Fischoff J. Psychosocial effects of sickle cell disease. Arch Int Med. 1974;133:681-689.
12. Vichinsky EP, Johnson R, Lubin BH. Multidisciplinary approach to pain management in sickle cell disease. Am J Ped, Hem/Oncol. 1982;4:328-333.
13. Treadwell MJ, Gil KM. Psychosocial aspects. In: Embury SH, Hebbel RP, Mohandas N, Steinberg MH, eds. Sickle Cell Disease: Basic Principles and Clinical Practice. New York, NY: Raven Press Ltd.; 1994:517.
14. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease: Rates and risk factors. N Engl J Med. 1991;325:11-16.
15. Gebhart GF, Hammond DL, Jansen TS, eds. Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management. Vol 2. Seattle, WA: IASP Press; 1994.
16. Melzack R. The tragedy of needless pain. Sci Am. 1990;262:27-33.
17. Jacox A, Carr DB, Payne R, et al. Clinical Practice Guideline No. 9: Management of Cancer Pain. Rockville, MD: US Agency for Health Care Policy and Research; 1994. AHCPR Publication 94-0592.
18. Principles of analgesic use in the treatment of acute pain and cancer pain. 3rd ed. Skokie, IL: American Pain Society; 1992.
19. Jaffe JH. Drug addiction and drug abuse. In: Goodman, Rall, Nies, Taylor, eds. The Pharmacological Basis of Therapeutics. NY, Pergamon Press; 1990:552.
20. Marks RM, Sachar EJ. Undertreatment of medical inpatients with narcotic analgesics. Ann Int Med. 1973;78:173-181.
21. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study ol hydroxyurea in Sickle Cell Anemia. N Engl J Med. 1995;332:1317-1322.
22. Benjamin LJ. Sickle cell pain. In: Max M, Portenoy R, Laska EM, eds. Advances in Pain Research and Therapy, the Design of Analgesic Clinical Trials. New York, NY: Raven Press Ltd.; 1990:317.
23. Foley KM. The treatment of cancer pain. N Engl J Med. 1985;313:84-95.
24. Payne R. Pain management in sickle cell disease: Rationale and techniques. In: Whitten C, Bartles J, eds. Sickle Cell Disease. New York, NY: Annals of NY Academy of Science; 1989: 565.
25. Thomas PF, Abrams M, Johnson-Telfair A, Firch K, Murphy M, Rosse W. Issues in Emergency Room treatment of sickle cell disease: The patient's perspective. 20th Annual Meeting of the National Sickle Cell Disease Program, Boston, MA; March 18-25,1995:108.
26. Alleyne J, Thomas VJ. The management of sickle cell crisis pain as experienced by patients and their carers. J Adv Nurs. 1994;19:725-732.
27. Koshy M, Leikin J, Dorn L, Lebby T, Talischy N, and Telfert MC. Evaluation and management of sickle cell disease in the emergency department (an 18-year experience):1974-1992. Amer J Therapeutics. 1994;1:309.
28. Moore D. Patient/physician model for painful crises: an alternative pathway for care. Presented at: 19th Annual Meeting of the National Sickle Cell Disease Program. Pain Symposium; March 23-26, 1994; New York, NY.
29. Cousins M. Acute and post-operative pain. In: Wall B, Melzack R, eds. Textbook of Pain. New York, NY: Churchill Livingstone; 1989:284.
30. Fishman B, Pasternak S, Wallenstein SL, Houde RW, Holland JC, Foley KM. The Memorial Pain Assessment card: A valid instrument for the evaluation of cancer pain. Cancer. 1987;60:1151-1158.
31. Cleeland CS, Ryan KM. Pain assessment: Global use of the brief pain inventory. Ann Acad Med Singapore. 1994;23:129-138.
32. Benjamin LJ, Edwards KR, Swinson GI, Cleeland CS. Use of the Brief Pain Inventory Short Form (BPISF) for assessment of acute sickle cell pain. Presented at: 21st Annual Meeting of the National Sickle Cell Disease Program; March 6-9, 1996; Mobile, AL. p 84.
33. Bruera E, Branneis C, Paterson AH, MacDonald RN. Use of methylphenidale as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage. 1984;4:3-6.
34. Shapiro BS, Cohen DE, Howe CJ. Patient-controlled analgesia for Sickle cell related pain. J Pain Symptom Manage. 1993;8:22-28.
35. Holbrook CT. Patient-controlled analgesia pain management for children with sickle cell disease. JAAMP. 1990;1:93-96.
36. Romberg PA. Pulmonary aspects of sickle cell disease. Arch Int Med. 1974;133:652
37. Embury SH, Garcia J, Mohandas N, Pennathur Das R, Clark MR. Effects of oxygen inhalation on endogenous erythropoietin kineticsm erythropoiesis, and properties of blood cells in sickle cell anemia. N Engl J Med. 1984;2311:291-295.
38. Reinhard EH, Moore CV, Dubach R, et al. Depressant effects of high concentration of inspired oxygen on erythrocytogenesis: Observations on patients with Sickle Cell Anemia with description of observed toxic manifestations of oxygen. J Clin Invest. 1944;23:682.
39. Gil KM, Phillips G, Abrams MR, Williams DA. Pain drawings and sickle disease pain. Clin J Pain. 1990;6:105-109.
40. Ransford AO, Caimo D, Mooney V. The pain drawing as an aid to the psychologic evaluation of patients with low back pain. Spine. 1972;1:127.
41. Benjamin LJ. Pain in sickle cell disease. In: Foley K, Payne R, eds: Current Therapy of Pain. Ontario, Canada: B.C. Decker, Inc.; 1989:90.
42. Ferrell BR, Griffith H. Cost Issues Related to Pain Management: Report from the Cancer Pain Panel of the Agency for Health Care Policy and Research. J Pain Symptom Manage. 1994;9:221-234.
43. Brookoff D, Polomano R. Treating sickle cell pain like cancer pain. Ann Intern Med. 1992;116:364-368.
44. Todd KH, Samaroo N, Hoffman JR. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA. 1993;269:1537-1539.
45. Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treatment of pain in minority patients with cancer. Ann of Int Med. 1997;127: 813-816.
46. Gil KM, Phillips G, Edens J, Martin NJ, Abrams M. Observation of pain behaviors during episodes of sickle cell disease pain. Clin J Pain. 1994;10: 128-132.
47. Armstrong ED, Pegelow CH, Gonzalez JC, Martinez A. Impact of children's sickle cell history on nurse and physician ratings of pain and medication decisions. J Pediatric Psychol. 1995;7:651-664.
48. Grossman SA, Sheidler VR, Swedeen K, Mucenski J, Piantadvosi S. Correlation of patient and care giver ratings of cancer pain. J Pain Symptom Manage. 1991;6:53-57.
49. Galer BS, Coyle N, Pasternak GW, Portenoy RK. Individual variability in the response to different opioids: report of five cases. Pain. 1992;49:87-91.
50. Tang RS, Shimomura SK, Rotblatt M. Meperidine-induced seizures in sickle cell patients. Hosp Formul. 1980;15:764.
51. Kaiko RF, Foley KM. Grabinski PY, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1989;13:180-185.
52. Wall PD. The prevention of post-operative pain. Pain. 1988;33:289-290.
53. Benjamin LJ, Swinson GI, Fulchon C, McKegney F. Frequently recurring pain in sickle cell disease. In: Beuzard Y, Lubin B, Rosa J, eds. Sickle Cell Disease and Thalassaemias: New Trends in Therapy. Vol 234. Paris, France: Colloque Inserm; 1994:433.
54. Davis H, Moore RM, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Report. 1997;112: 40-43.
55. Wood K, Karrison T, Koshy M, Patel A, Friedmann P, Cassel C. Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Report. 1997;112:44.
56. Serjeant GR, Ceulaer CD, Lethbridge R, Morris J, Singhal A, Thomas PW. The painful crisis of homozygous sickle cell disease: clinical features. Brit J Haem. 1994;87:586-591.
57. Platt A, Eckman J. The cost and benefits of operating a 24 hour comprehensive sickle cell center [abstract]. Presented at the 18th Annual Meeting of the National Sickle Cell Disease Program, Philadelphia, PA; May 23-25, 1993.
58. Cleeland, CS. Analgesic trials to clinical practice. When and how does it happen? In: Max M, Portenoy R, and Lasko E, eds. Advances in Pain Research and Therapy. Vol 18. New York, NY: Raven Press Ltd.; 1991.
59. Miaskowski C., Nichols R, Brody R, et al. Putting the cancer pain guidelines into practice. Capsules and Comments in Oncology Nursing. 1995;3:9-15.
60. Max, M. Improving outcomes of analgesic treatment: Is education enough? Annals Intern Med. 1990;113:885-9.
61. Dahl JL, Berry PH, Skemp MM, Patterson CH, Wuest JM. Institutionalizing Pain Management: Making Pain Assessment and Treatment an Integral Part of the JCAHO's Standards and Survey Process [abstract]. Presented at: 9th World Congress on Pain, International Association for the Study of Pain: August 22-27, 1999, Vienna, Austria. IASP Press 472.